V gamma 9V delta 2 T cell response to colon carcinoma cells
During analysis of CD8 T cells derived from ascites of a colon cancer patient, we isolated a Vgamma9Vdelta2 T cell clone showing strong reactivity against autologous tumor cell lines. This clone killed a large fraction of allogeneic colon carcinoma and melanoma cell lines, but did not affect a norma...
Gespeichert in:
Veröffentlicht in: | The Journal of immunology (1950) 2005-10, Vol.175 (8), p.5481-5488 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 5488 |
---|---|
container_issue | 8 |
container_start_page | 5481 |
container_title | The Journal of immunology (1950) |
container_volume | 175 |
creator | Corvaisier, Murielle Moreau-Aubry, Agnès Diez, Elisabeth Bennouna, Jaafar Mosnier, Jean-Francois Scotet, Emmanuel Bonneville, Marc Jotereau, Francine |
description | During analysis of CD8 T cells derived from ascites of a colon cancer patient, we isolated a Vgamma9Vdelta2 T cell clone showing strong reactivity against autologous tumor cell lines. This clone killed a large fraction of allogeneic colon carcinoma and melanoma cell lines, but did not affect a normal colon cell line, colon fibroblasts, or melanocytes. Tumor cell recognition was TCR and NKG2D dependent and induced TNF-alpha and IFN-gamma secretion by the clone; accordingly, tumor targets expressed several NKG2D ligands, such as MHC class I chain-related gene A and UL16-binding protein molecules. Colon tumor recognition by Vgamma9Vdelta2 T cells was highly dependent on isopentenyl pyrophosphate production and ICAM-1 expression by target cells. Finally, similar reactivity patterns against colon carcinoma cell lines were observed using polyclonal Vgamma9Vdelta2 T cells of various origins, and Vgamma9Vdelta2 lymphocytes were present in the majority of colon tumor samples studied. Together, these results suggest that Vgamma9Vdelta2 T cells contribute to the natural immune surveillance against colon cancers. Therefore, this study provides a strong rationale for the use of Vgamma9Vdelta2 T cell agonists in immunotherapies targeting colon tumors. |
doi_str_mv | 10.4049/jimmunol.175.8.5481 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68668993</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17595153</sourcerecordid><originalsourceid>FETCH-LOGICAL-p170t-3e83f275fec2213947f5ca651dfb6f988d474e30c1bb0dd7a735bc7626250b373</originalsourceid><addsrcrecordid>eNqF0LtOwzAYBWAPIFoKT4CEPLEl_L7bYkIVN6kSS-kaOY6DUtlxiJOBt6cVZWY6y6ejo4PQDYGSAzf3-y7GuU-hJEqUuhRckzO0BKC0IEqqBbrMeQ8AEii_QAsiKQEp5BI97PCnjdFis8OND5PFFG-x8yHg0ech9dnjKWGXQuqxs6Pr-nTQR5Cv0HlrQ_bXp1yhj-en7fq12Ly_vK0fN8VAFEwF85q1VInWO0oJM1y1wlkpSNPWsjVaN1xxz8CRuoamUVYxUTslqaQCaqbYCt399g5j-pp9nqrY5eMC2_s050pqKbUx7F94OMcIIo7w9gTnOvqmGsYu2vG7-vuF_QBWpGKD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17595153</pqid></control><display><type>article</type><title>V gamma 9V delta 2 T cell response to colon carcinoma cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Corvaisier, Murielle ; Moreau-Aubry, Agnès ; Diez, Elisabeth ; Bennouna, Jaafar ; Mosnier, Jean-Francois ; Scotet, Emmanuel ; Bonneville, Marc ; Jotereau, Francine</creator><creatorcontrib>Corvaisier, Murielle ; Moreau-Aubry, Agnès ; Diez, Elisabeth ; Bennouna, Jaafar ; Mosnier, Jean-Francois ; Scotet, Emmanuel ; Bonneville, Marc ; Jotereau, Francine</creatorcontrib><description>During analysis of CD8 T cells derived from ascites of a colon cancer patient, we isolated a Vgamma9Vdelta2 T cell clone showing strong reactivity against autologous tumor cell lines. This clone killed a large fraction of allogeneic colon carcinoma and melanoma cell lines, but did not affect a normal colon cell line, colon fibroblasts, or melanocytes. Tumor cell recognition was TCR and NKG2D dependent and induced TNF-alpha and IFN-gamma secretion by the clone; accordingly, tumor targets expressed several NKG2D ligands, such as MHC class I chain-related gene A and UL16-binding protein molecules. Colon tumor recognition by Vgamma9Vdelta2 T cells was highly dependent on isopentenyl pyrophosphate production and ICAM-1 expression by target cells. Finally, similar reactivity patterns against colon carcinoma cell lines were observed using polyclonal Vgamma9Vdelta2 T cells of various origins, and Vgamma9Vdelta2 lymphocytes were present in the majority of colon tumor samples studied. Together, these results suggest that Vgamma9Vdelta2 T cells contribute to the natural immune surveillance against colon cancers. Therefore, this study provides a strong rationale for the use of Vgamma9Vdelta2 T cell agonists in immunotherapies targeting colon tumors.</description><identifier>ISSN: 0022-1767</identifier><identifier>DOI: 10.4049/jimmunol.175.8.5481</identifier><identifier>PMID: 16210656</identifier><language>eng</language><publisher>United States</publisher><subject>Antigens - immunology ; Caco-2 Cells ; Cell Line, Tumor ; Clone Cells ; Colonic Neoplasms - immunology ; Colonic Neoplasms - pathology ; Cytotoxicity, Immunologic ; HCT116 Cells ; HT29 Cells ; Humans ; Intercellular Adhesion Molecule-1 - biosynthesis ; Intercellular Adhesion Molecule-1 - genetics ; NK Cell Lectin-Like Receptor Subfamily K ; Receptors, Antigen, T-Cell, gamma-delta - immunology ; Receptors, Immunologic - immunology ; Receptors, Natural Killer Cell ; T-Lymphocyte Subsets - immunology</subject><ispartof>The Journal of immunology (1950), 2005-10, Vol.175 (8), p.5481-5488</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16210656$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Corvaisier, Murielle</creatorcontrib><creatorcontrib>Moreau-Aubry, Agnès</creatorcontrib><creatorcontrib>Diez, Elisabeth</creatorcontrib><creatorcontrib>Bennouna, Jaafar</creatorcontrib><creatorcontrib>Mosnier, Jean-Francois</creatorcontrib><creatorcontrib>Scotet, Emmanuel</creatorcontrib><creatorcontrib>Bonneville, Marc</creatorcontrib><creatorcontrib>Jotereau, Francine</creatorcontrib><title>V gamma 9V delta 2 T cell response to colon carcinoma cells</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>During analysis of CD8 T cells derived from ascites of a colon cancer patient, we isolated a Vgamma9Vdelta2 T cell clone showing strong reactivity against autologous tumor cell lines. This clone killed a large fraction of allogeneic colon carcinoma and melanoma cell lines, but did not affect a normal colon cell line, colon fibroblasts, or melanocytes. Tumor cell recognition was TCR and NKG2D dependent and induced TNF-alpha and IFN-gamma secretion by the clone; accordingly, tumor targets expressed several NKG2D ligands, such as MHC class I chain-related gene A and UL16-binding protein molecules. Colon tumor recognition by Vgamma9Vdelta2 T cells was highly dependent on isopentenyl pyrophosphate production and ICAM-1 expression by target cells. Finally, similar reactivity patterns against colon carcinoma cell lines were observed using polyclonal Vgamma9Vdelta2 T cells of various origins, and Vgamma9Vdelta2 lymphocytes were present in the majority of colon tumor samples studied. Together, these results suggest that Vgamma9Vdelta2 T cells contribute to the natural immune surveillance against colon cancers. Therefore, this study provides a strong rationale for the use of Vgamma9Vdelta2 T cell agonists in immunotherapies targeting colon tumors.</description><subject>Antigens - immunology</subject><subject>Caco-2 Cells</subject><subject>Cell Line, Tumor</subject><subject>Clone Cells</subject><subject>Colonic Neoplasms - immunology</subject><subject>Colonic Neoplasms - pathology</subject><subject>Cytotoxicity, Immunologic</subject><subject>HCT116 Cells</subject><subject>HT29 Cells</subject><subject>Humans</subject><subject>Intercellular Adhesion Molecule-1 - biosynthesis</subject><subject>Intercellular Adhesion Molecule-1 - genetics</subject><subject>NK Cell Lectin-Like Receptor Subfamily K</subject><subject>Receptors, Antigen, T-Cell, gamma-delta - immunology</subject><subject>Receptors, Immunologic - immunology</subject><subject>Receptors, Natural Killer Cell</subject><subject>T-Lymphocyte Subsets - immunology</subject><issn>0022-1767</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0LtOwzAYBWAPIFoKT4CEPLEl_L7bYkIVN6kSS-kaOY6DUtlxiJOBt6cVZWY6y6ejo4PQDYGSAzf3-y7GuU-hJEqUuhRckzO0BKC0IEqqBbrMeQ8AEii_QAsiKQEp5BI97PCnjdFis8OND5PFFG-x8yHg0ech9dnjKWGXQuqxs6Pr-nTQR5Cv0HlrQ_bXp1yhj-en7fq12Ly_vK0fN8VAFEwF85q1VInWO0oJM1y1wlkpSNPWsjVaN1xxz8CRuoamUVYxUTslqaQCaqbYCt399g5j-pp9nqrY5eMC2_s050pqKbUx7F94OMcIIo7w9gTnOvqmGsYu2vG7-vuF_QBWpGKD</recordid><startdate>20051015</startdate><enddate>20051015</enddate><creator>Corvaisier, Murielle</creator><creator>Moreau-Aubry, Agnès</creator><creator>Diez, Elisabeth</creator><creator>Bennouna, Jaafar</creator><creator>Mosnier, Jean-Francois</creator><creator>Scotet, Emmanuel</creator><creator>Bonneville, Marc</creator><creator>Jotereau, Francine</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20051015</creationdate><title>V gamma 9V delta 2 T cell response to colon carcinoma cells</title><author>Corvaisier, Murielle ; Moreau-Aubry, Agnès ; Diez, Elisabeth ; Bennouna, Jaafar ; Mosnier, Jean-Francois ; Scotet, Emmanuel ; Bonneville, Marc ; Jotereau, Francine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p170t-3e83f275fec2213947f5ca651dfb6f988d474e30c1bb0dd7a735bc7626250b373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Antigens - immunology</topic><topic>Caco-2 Cells</topic><topic>Cell Line, Tumor</topic><topic>Clone Cells</topic><topic>Colonic Neoplasms - immunology</topic><topic>Colonic Neoplasms - pathology</topic><topic>Cytotoxicity, Immunologic</topic><topic>HCT116 Cells</topic><topic>HT29 Cells</topic><topic>Humans</topic><topic>Intercellular Adhesion Molecule-1 - biosynthesis</topic><topic>Intercellular Adhesion Molecule-1 - genetics</topic><topic>NK Cell Lectin-Like Receptor Subfamily K</topic><topic>Receptors, Antigen, T-Cell, gamma-delta - immunology</topic><topic>Receptors, Immunologic - immunology</topic><topic>Receptors, Natural Killer Cell</topic><topic>T-Lymphocyte Subsets - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Corvaisier, Murielle</creatorcontrib><creatorcontrib>Moreau-Aubry, Agnès</creatorcontrib><creatorcontrib>Diez, Elisabeth</creatorcontrib><creatorcontrib>Bennouna, Jaafar</creatorcontrib><creatorcontrib>Mosnier, Jean-Francois</creatorcontrib><creatorcontrib>Scotet, Emmanuel</creatorcontrib><creatorcontrib>Bonneville, Marc</creatorcontrib><creatorcontrib>Jotereau, Francine</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Corvaisier, Murielle</au><au>Moreau-Aubry, Agnès</au><au>Diez, Elisabeth</au><au>Bennouna, Jaafar</au><au>Mosnier, Jean-Francois</au><au>Scotet, Emmanuel</au><au>Bonneville, Marc</au><au>Jotereau, Francine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>V gamma 9V delta 2 T cell response to colon carcinoma cells</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2005-10-15</date><risdate>2005</risdate><volume>175</volume><issue>8</issue><spage>5481</spage><epage>5488</epage><pages>5481-5488</pages><issn>0022-1767</issn><abstract>During analysis of CD8 T cells derived from ascites of a colon cancer patient, we isolated a Vgamma9Vdelta2 T cell clone showing strong reactivity against autologous tumor cell lines. This clone killed a large fraction of allogeneic colon carcinoma and melanoma cell lines, but did not affect a normal colon cell line, colon fibroblasts, or melanocytes. Tumor cell recognition was TCR and NKG2D dependent and induced TNF-alpha and IFN-gamma secretion by the clone; accordingly, tumor targets expressed several NKG2D ligands, such as MHC class I chain-related gene A and UL16-binding protein molecules. Colon tumor recognition by Vgamma9Vdelta2 T cells was highly dependent on isopentenyl pyrophosphate production and ICAM-1 expression by target cells. Finally, similar reactivity patterns against colon carcinoma cell lines were observed using polyclonal Vgamma9Vdelta2 T cells of various origins, and Vgamma9Vdelta2 lymphocytes were present in the majority of colon tumor samples studied. Together, these results suggest that Vgamma9Vdelta2 T cells contribute to the natural immune surveillance against colon cancers. Therefore, this study provides a strong rationale for the use of Vgamma9Vdelta2 T cell agonists in immunotherapies targeting colon tumors.</abstract><cop>United States</cop><pmid>16210656</pmid><doi>10.4049/jimmunol.175.8.5481</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1767 |
ispartof | The Journal of immunology (1950), 2005-10, Vol.175 (8), p.5481-5488 |
issn | 0022-1767 |
language | eng |
recordid | cdi_proquest_miscellaneous_68668993 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Antigens - immunology Caco-2 Cells Cell Line, Tumor Clone Cells Colonic Neoplasms - immunology Colonic Neoplasms - pathology Cytotoxicity, Immunologic HCT116 Cells HT29 Cells Humans Intercellular Adhesion Molecule-1 - biosynthesis Intercellular Adhesion Molecule-1 - genetics NK Cell Lectin-Like Receptor Subfamily K Receptors, Antigen, T-Cell, gamma-delta - immunology Receptors, Immunologic - immunology Receptors, Natural Killer Cell T-Lymphocyte Subsets - immunology |
title | V gamma 9V delta 2 T cell response to colon carcinoma cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A42%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=V%20gamma%209V%20delta%202%20T%20cell%20response%20to%20colon%20carcinoma%20cells&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Corvaisier,%20Murielle&rft.date=2005-10-15&rft.volume=175&rft.issue=8&rft.spage=5481&rft.epage=5488&rft.pages=5481-5488&rft.issn=0022-1767&rft_id=info:doi/10.4049/jimmunol.175.8.5481&rft_dat=%3Cproquest_pubme%3E17595153%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17595153&rft_id=info:pmid/16210656&rfr_iscdi=true |